Management of Aromatase Inhibitor-Associated Bone Loss (AIBL) in postmenopausal women with hormone sensitive breast cancer: Joint position statement of the IOF, CABS, ECTS, IEG, ESCEO, IMS, and SIOG

P Hadji, MS Aapro, JJ Body, M Gnant, ML Brandi, JY Reginster, M.C. Zillikens, CC Gluer, T de Villiers, R Baber, GD Roodman, C Cooper, B Langdahl, S Palacios, J Kanis, N Al-Daghri, X Nogues, EF Eriksen, A Kurth, R RizzoliRE Coleman

Research output: Contribution to journalArticleAcademicpeer-review

227 Citations (Scopus)
24 Downloads (Pure)
Original languageUndefined/Unknown
Pages (from-to)1-12
Number of pages12
JournalJournal of Bone Oncology
Volume7
DOIs
Publication statusPublished - 2017

Research programs

  • EMC OR-01

Cite this